Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

1.

Agile, a guiding principle for health care improvement?

Tolf S, Nyström ME, Tishelman C, Brommels M, Hansson J.

Int J Health Care Qual Assur. 2015;28(5):468-93. doi: 10.1108/IJHCQA-04-2014-0044.

PMID:
26020429
2.

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

Basset-Seguin N, Hauschild A, Grob JJ, Kunstfeld R, Dréno B, Mortier L, Ascierto PA, Licitra L, Dutriaux C, Thomas L, Jouary T, Meyer N, Guillot B, Dummer R, Fife K, Ernst DS, Williams S, Fittipaldo A, Xynos I, Hansson J.

Lancet Oncol. 2015 May 13. pii: S1470-2045(15)70198-1. doi: 10.1016/S1470-2045(15)70198-1. [Epub ahead of print]

PMID:
25981813
3.

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.

Lazar V, Rubin E, Depil S, Pawitan Y, Martini JF, Gomez-Navarro J, Yver A, Kan Z, Dry JR, Kehren J, Validire P, Rodon J, Vielh P, Ducreux M, Galbraith S, Lehnert M, Onn A, Berger R, Pierotti MA, Porgador A, Pramesh CS, Ye DW, Carvalho AL, Batist G, Le Chevalier T, Morice P, Besse B, Vassal G, Mortlock A, Hansson J, Berindan-Neagoe I, Dann R, Haspel J, Irimie A, Laderman S, Nechushtan H, Al Omari AS, Haywood T, Bresson C, Soo KC, Osman I, Mata H, Lee JJ, Jhaveri K, Meurice G, Palmer G, Lacroix L, Koscielny S, Eterovic KA, Blay JY, Buller R, Eggermont A, Schilsky RL, Mendelsohn J, Soria JC, Rothenberg M, Scoazec JY, Hong WK, Kurzrock R.

Oncotarget. 2015 Apr 3. [Epub ahead of print]

4.

CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.

Helgadottir H, Höiom V, Tuominen R, Jönsson G, Månsson-Brahme E, Olsson H, Hansson J.

Int J Cancer. 2015 May 5. doi: 10.1002/ijc.29595. [Epub ahead of print]

PMID:
25943250
5.

Implementation of evidence-based rehabilitation for non-specific back pain and common mental health problems: a process evaluation of a nationwide initiative.

Brämberg EB, Klinga C, Jensen I, Busch H, Bergström G, Brommels M, Hansson J.

BMC Health Serv Res. 2015 Feb 28;15:79. doi: 10.1186/s12913-015-0740-4.

6.

Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.

Del Chiaro M, Verbeke CS, Kartalis N, Pozzi Mucelli R, Gustafsson P, Hansson J, Haas SL, Segersvärd R, Andren-Sandberg Å, Löhr JM.

JAMA Surg. 2015 Apr 8. doi: 10.1001/jamasurg.2014.3852. [Epub ahead of print]

PMID:
25853369
7.

Estimating effective dose from 3D imaging with interventional fluoroscopy systems using limited exposure data.

Svalkvist A, Hansson J, Båth M.

Acta Radiol. 2015 Apr 7. pii: 0284185115579079. [Epub ahead of print]

PMID:
25852194
8.

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.

Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM.

Cancer Immunol Immunother. 2015 Apr 2. [Epub ahead of print]

PMID:
25832001
9.

Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation.

Pico de Coaña Y, Wolodarski M, Gentilcore G, Yoshimoto Y, Poschke I, Hansson J, Masucci GV, Kiessling R.

J Transl Med. 2015;13:2064. doi: 10.1186/1479-5876-13-S1-O7. No abstract available.

10.

TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.

Jangard M, Zebary A, Ragnarsson-Olding B, Hansson J.

Melanoma Res. 2015 Jun;25(3):185-8. doi: 10.1097/CMR.0000000000000148.

PMID:
25746036
11.

VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy.

Schwaederlé M, Lazar V, Validire P, Hansson J, Lacroix L, Soria JC, Pawitan Y, Kurzrock R.

Cancer Res. 2015 Apr 1;75(7):1187-90. doi: 10.1158/0008-5472.CAN-14-2305. Epub 2015 Feb 11.

PMID:
25672981
12.

BRAFV600E Protein Expression in Primary Cutaneous Malignant Melanomas and Paired Metastases.

Eriksson H, Zebary A, Vassilaki I, Omholt K, Ghaderi M, Hansson J.

JAMA Dermatol. 2015 Apr 1;151(4):410-6. doi: 10.1001/jamadermatol.2014.3689.

PMID:
25588152
13.

Heart block and acute kidney injury due to hyperparathyroidism-induced hypercalcemic crisis.

Brown TC, Healy JM, McDonald MJ, Hansson JH, Quinn CE.

Yale J Biol Med. 2014 Dec 12;87(4):563-7. eCollection 2014 Dec.

14.

Transcriptome-wide profiling and posttranscriptional analysis of hematopoietic stem/progenitor cell differentiation toward myeloid commitment.

Klimmeck D, Cabezas-Wallscheid N, Reyes A, von Paleske L, Renders S, Hansson J, Krijgsveld J, Huber W, Trumpp A.

Stem Cell Reports. 2014 Nov 11;3(5):858-75. doi: 10.1016/j.stemcr.2014.08.012. Epub 2014 Sep 25.

15.

Microfluidic-based isolation of bacteria from whole blood for sepsis diagnostics.

Zelenin S, Hansson J, Ardabili S, Ramachandraiah H, Brismar H, Russom A.

Biotechnol Lett. 2015 Apr;37(4):825-30. doi: 10.1007/s10529-014-1734-8. Epub 2014 Nov 21.

PMID:
25413883
16.

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.

Tuominen R, Jewell R, van den Oord JJ, Wolter P, Stierner U, Lindholm C, Hertzman Johansson C, Lindén D, Johansson H, Frostvik Stolt M, Walker C, Snowden H, Newton-Bishop J, Hansson J, Egyházi Brage S.

Int J Cancer. 2015 Jun 15;136(12):2844-53. doi: 10.1002/ijc.29332. Epub 2014 Nov 24.

PMID:
25400033
17.

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.

Lyth J, Eriksson H, Hansson J, Ingvar C, Jansson M, Lapins J, Månsson-Brahme E, Naredi P, Stierner U, Ullenhag G, Carstensen J, Lindholm C.

Br J Dermatol. 2015 Mar;172(3):700-6. doi: 10.1111/bjd.13483. Epub 2015 Feb 5.

PMID:
25323770
18.

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhönen S, Syrjänen K, Lundin J, Hernberg M.

Cancer Immunol Immunother. 2015 Feb;64(2):173-80. doi: 10.1007/s00262-014-1620-1. Epub 2014 Oct 16.

PMID:
25319807
19.

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.

Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K.

N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29.

20.

The effect on melanoma risk of genes previously associated with telomere length.

Iles MM, Bishop DT, Taylor JC, Hayward NK, Brossard M, Cust AE, Dunning AM, Lee JE, Moses EK, Akslen LA; AMFS Investigators, Andresen PA, Avril MF, Azizi E, Scarrà GB, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Harland M, Helsing P, Hočevar M, Höiom V; IBD investigators, Ingvar C, Kanetsky PA, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Martin NG, Molven A, Montgomery GW, Novaković S, Olsson H, Puig S, Puig-Butille JA; QMEGA and QTWIN Investigators, Radford-Smith GL, Randerson-Moor J; SDH Study Group, van der Stoep N, van Doorn R, Whiteman DC, MacGregor S, Pooley KA, Ward SV, Mann GJ, Amos CI, Pharoah PD, Demenais F, Law MH, Newton Bishop JA, Barrett JH; GenoMEL Consortium.

J Natl Cancer Inst. 2014 Sep 17;106(10). pii: dju267. doi: 10.1093/jnci/dju267. Print 2014 Oct.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk